Characteristic | 5-year CCS | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|
χ2 test | P | HR(95%CI) | P | ||
Year of diagnosis | 2.412 | 0.120 | NI | ||
2004–2007 | 78.4% | ||||
2008–2010 | 80.2% | ||||
Sex | 1.655 | 0.198 | NI | ||
Male | 29.5% | ||||
Female | 78.4% | ||||
Age | 21.805 | 0.000 | 0.000 | ||
< 60 | 81.3% | Ref | |||
≥ 60 | 76.4% | 0.777 (0.697 ~ 0.866) | 0.000 | ||
Race | 14.873 | 0.000 | 0.909 | ||
White | 79.5% | Ref | |||
Black | 72.7% | 1.129 (0.937 ~ 1.364) | 0.202 | ||
Others | 81.8% | 1.585 (1.246 ~ 2.017) | 0.000 | ||
Grade | 112.363 | 0.000 | 0.000 | ||
Grade I/ II | 81.5% | Ref | |||
Grade III/ IV | 66.9% | 0.596 (0.523 ~ 0.680) | 0.000 | ||
Histologic type | 81.128 | 0.000 | 0.000 | ||
Adenocarcinoma | 80.4% | Ref | |||
Mucinous adenocarcinoma | 69.2% | 0.412 (0.308 ~ 0.635) | 0.000 | ||
Signet ring cell carcinoma | 32.5% | 0.601 (0.408 ~ 0.885) | 0.010 | ||
ypT stage | 148.323 | 0.000 | 0.000 | ||
1 | 88.6% | Ref | |||
2 | 87.9% | 0.293 (0.212 ~ 0.405) | 0.000 | ||
3 | 77.9% | 0.303 (0.239 ~ 0.384) | 0.000 | ||
4 | 62.6% | 0.584 (0.494 ~ 0.692) | 0.000 | ||
LNs | 2.234 | 0.135 | NI | ||
≤ 12 | 78.5% | ||||
> 12 | 79.8% | ||||
NLN | 78.060 | 0.000 | 0.000 | ||
≤ 9 | 74.3% | Ref | |||
> 9 | 82.8% | 1.623 (1.457 ~ 1.809) | 0.000 |